Target intelligence / Profile preview

Tubulin beta chain (parasite) (β-tubulin)

Target
β-tubulin
Molecular classification
Cytoskeletal protein, Microtubule protein, Tubulin superfamily member
01

Overview

Parasite β-tubulin refers specifically to the beta subunit of tubulin found in protozoan parasites such as *Plasmodium* spp. (malaria), *Toxoplasma gondii*, and *Cryptosporidium parvum*. Tubulins are globular proteins that polymerize into microtubules—key components of the cytoskeleton responsible for maintaining cell shape, enabling motility/invasion mechanisms unique to apicomplexan parasites, facilitating chromosome segregation during mitosis/cytokinesis, and supporting organelle positioning[1][2][3]. The structure-function relationship of these proteins underpins their role as validated therapeutic targets; disruption leads directly to loss of viability or infectivity. While highly conserved across eukaryotes—including humans—subtle sequence differences allow selective targeting by certain antiparasitic drugs. However, cross-reactivity with host tubulins remains a challenge for drug development[5].

Other names
Beta-tubulinTubulin beta chainParasite β-tubulin (context-specific, e.g., Plasmodium β-tubulin, Toxoplasma β-tubulin)
02

Mechanism of action

Drugs targeting parasite β-tubulins typically: - Bind to the colchicine site or other sites on the tubulin dimer. - Inhibit microtubule polymerization or destabilize existing microtubules. - Disrupt essential processes such as mitosis, organelle transport, motility, and invasion—leading to impaired growth or death of the parasite.

03

Biological functions

Microtubule formation and dynamicsCell division (mitosis and cytokinesis)Maintenance of cell shape and rigidityMotility and host cell invasion in parasitesOrganelle segregation during replication
04

Disease associations

Infection (notably malaria, toxoplasmosis, cryptosporidiosis)Essential for parasite proliferation and transmission within the host
05

Safety considerations

Potential off-target effects on host/human tubulins leading to toxicity.Selectivity between parasite and human isoforms is critical but sometimes limited.Resistance development due to mutations in the target gene.
06

Interacting drugs

Albendazole

3 more in the full profile.

07

Biomarkers

No widely used clinical biomarkers specific to parasite β-tubulin are established for patient selection. However:Mutations in the β-tubulin gene can serve as markers of drug resistance in some parasitic species.

Beyond the preview

Go deeper on Tubulin beta chain (parasite) (β-tubulin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin beta chain (parasite) (β-tubulin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call